Research Innovation Ospedale San Raffaele is actively involved in developing cutting-edge CRISPR-based treatments in collaboration with major biotech firms like Novartis and Regeneron, presenting opportunities for partnerships in biotech research tools or advanced therapeutic technologies.
Scientific Collaboration The hospital's strong integration of research, medicine, and university education indicates potential for educational software, research management systems, and scientific equipment procurement.
Financial Scope With a revenue between 100 million and 250 million dollars, Ospedale San Raffaele has substantial budget capacity for investing in healthcare innovations, medical devices, and IT infrastructure upgrades.
Technology Usage The hospital’s technology stack includes advanced platforms such as Google Maps, PWA, and Citrix, highlighting openness to digital transformation and cloud-based solutions, ideal for targeted software or cloud service offerings.
Market Potential As part of Gruppo San Donato and comparable to other large healthcare providers, the hospital presents opportunities for expanding product and service offerings in research support, patient management, and healthcare IT solutions.